Kayne Anderson Rudnick Investment Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$519K Sell
10,773
-996
-8% -$46.4K ﹤0.01% 434
2025
Q4
$570K Sell
11,769
-401
-3% -$19.9K ﹤0.01% 437
2025
Q3
$574K Sell
12,170
-1
-0% -$48 ﹤0.01% 430
2025
Q2
$588K Buy
12,171
+78
+0.6% +$3.98K ﹤0.01% 420
2025
Q1
$671K Sell
12,093
-798
-6% -$43.2K ﹤0.01% 405
2024
Q4
$622K Sell
12,891
-476
-4% -$24.2K ﹤0.01% 403
2024
Q3
$770K Sell
13,367
-3,281
-20% -$177K ﹤0.01% 394
2024
Q2
$808K Sell
16,648
-488
-3% -$23.5K ﹤0.01% 403
2024
Q1
$833K Sell
17,136
-4,723
-22% -$231K ﹤0.01% 381
2023
Q4
$1.09M Sell
21,859
-379
-2% -$18.5K ﹤0.01% 359
2023
Q3
$1.19M Sell
22,238
-3,561
-14% -$190K ﹤0.01% 357
2023
Q2
$1.39M Sell
25,799
-8,873
-26% -$477K ﹤0.01% 353
2023
Q1
$1.89M Sell
34,672
-557
-2% -$27.1K 0.01% 326
2022
Q4
$1.71M Buy
35,229
+4,288
+14% +$188K 0.01% 337
2022
Q3
$1.18M Sell
30,941
-3,323
-10% -$148K ﹤0.01% 342
2022
Q2
$1.71M Buy
34,264
+10
+0% +$531 0.01% 324
2022
Q1
$1.76M Sell
34,254
-782
-2% -$40.4K ﹤0.01% 315
2021
Q4
$1.75M Sell
35,036
-419
-1% -$20.7K ﹤0.01% 319
2021
Q3
$1.71M Buy
35,455
+1,051
+3% +$53.4K ﹤0.01% 309
2021
Q2
$1.81M Sell
34,404
-199
-0.6% -$10.4K ﹤0.01% 302
2021
Q1
$1.71M Buy
34,603
+2,032
+6% +$97.6K ﹤0.01% 298
2020
Q4
$1.58M Buy
32,571
+2,863
+10% +$141K ﹤0.01% 301
2020
Q3
$1.49M Sell
29,708
-1,779
-6% -$91.6K 0.01% 291
2020
Q2
$1.61M Sell
31,487
-11,629
-27% -$565K 0.01% 290
2020
Q1
$1.89M Sell
43,116
-1,289
-3% -$61.7K 0.01% 262
2019
Q4
$2.23M Sell
44,405
-122
-0.3% -$5.71K 0.01% 268
2019
Q3
$2.06M Buy
44,527
+2,431
+6% +$105K 0.01% 265
2019
Q2
$1.82M Sell
42,096
-1,952
-4% -$83K 0.01% 271
2019
Q1
$1.95M Sell
44,048
-6,491
-13% -$278K 0.01% 252
2018
Q4
$2.19M Sell
50,539
-13,061
-21% -$576K 0.02% 254
2018
Q3
$2.84M Sell
63,600
-34
-0.1% -$1.45K 0.02% 232
2018
Q2
$2.55M Sell
63,634
-3,548
-5% -$140K 0.02% 234
2018
Q1
$2.69M Buy
67,182
+14,060
+26% +$585K 0.02% 224
2017
Q4
$2.28M Buy
53,122
+1,506
+3% +$69.4K 0.02% 249
2017
Q3
$2.57M Sell
51,616
-3
-0% -$145 0.02% 233
2017
Q2
$2.47M Sell
51,619
-294
-0.6% -$14.1K 0.02% 233
2017
Q1
$2.35M Buy
51,913
+6,038
+13% +$256K 0.03% 245
2016
Q4
$1.85M Sell
45,875
-5,545
-11% -$218K 0.02% 259
2016
Q3
$1.96M Sell
51,420
-286
-0.6% -$11.5K 0.02% 250
2016
Q2
$2.16M Sell
51,706
-300
-0.6% -$12.3K 0.03% 229
2016
Q1
$2.09M Sell
52,006
-18,494
-26% -$743K 0.03% 219
2015
Q4
$3.01M Sell
70,500
-10,223
-13% -$470K 0.05% 190
2015
Q3
$3.83M Sell
80,723
-15,804
-16% -$805K 0.07% 173
2015
Q2
$4.78M Buy
96,527
+4,094
+4% +$207K 0.07% 164
2015
Q1
$4.57M Buy
92,433
+18,244
+25% +$872K 0.07% 164
2014
Q4
$3.38M Buy
74,189
+2,068
+3% +$100K 0.06% 181
2014
Q3
$4.07M Buy
72,121
+8,089
+13% +$434K 0.07% 170
2014
Q2
$3.4M Buy
64,032
+3,896
+6% +$207K 0.06% 179
2014
Q1
$3.14M Buy
60,136
+12,416
+26% +$628K 0.06% 180
2013
Q4
$2.56M Buy
47,720
+3,587
+8% +$185K 0.04% 184
2013
Q3
$2.23M Buy
44,133
+1,762
+4% +$89.7K 0.04% 185
2013
Q2
$2.18M Buy
+42,371
New +$2.26M 0.04% 182

Other funds holding SNY

Kayne Anderson Rudnick Investment Management's SNY Position: Q1 2026 in Review

Kayne Anderson Rudnick Investment Management reduced its Sanofi (SNY) stake by 8.5% in Q1 2026, selling an estimated $46.4K and leaving 10,773 shares worth $519K. The position accounts for ﹤0.01% of the portfolio, ranked #434.

Kayne Anderson Rudnick Investment Management first reported a position in SNY in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.78M in Q2 2015. 743 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Kayne Anderson Rudnick Investment Management held 10,773 shares of Sanofi worth $519K as of Q1 2026.
  • Kayne Anderson Rudnick Investment Management sold 996 Sanofi shares in Q1 2026, an estimated $46.4K.
  • Sanofi made up ﹤0.01% of Kayne Anderson Rudnick Investment Management's portfolio in Q1 2026, its #434 holding.
  • Kayne Anderson Rudnick Investment Management first reported a position in Sanofi in Q2 2013 and has held it in 52 quarters since.
  • Kayne Anderson Rudnick Investment Management's Sanofi position peaked at $4.78M in Q2 2015.
  • 743 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q1 2026, filed 14 May 2026.